<DOC>
	<DOCNO>NCT02118467</DOCNO>
	<brief_summary>The investigator hypothesis ICU patient shock , use vasoactive drug phenylephrine vasopressin reduce tachydysrhythmias compare norepinephrine epinephrine . To investigate hypothesis , investigator conduct randomized double blind control trial compare phenylephrine vasopressin vs. norepinephrine epinephrine ICU patient shock responsive IV fluid . All patient admit adult intensive care unit University Chicago screen eligibility .</brief_summary>
	<brief_title>Vasoactive Drugs Intensive Care Unit</brief_title>
	<detailed_description>Shock , define inadequate tissue perfusion , common problem critically ill patient . Most patient shock hypotension typically treat initially intravenous fluid resuscitation patient fluid responsive . If patient remain hypotensive , typically treat vasoactive medication . Four commonly used FDA approve vasoactive medication norepinephrine , phenylephrine , epinephrine , vasopressin . Apart 2010 trial compare norepinephrine dopamine , study date show one four above-mentioned vasoactive medication superior another . Accordingly , choice vasoactive medication base upon individual physician preference , without outcomes-related evidence base . Two four mention vasoactive medication ( norepinephrine epinephrine ) chronotropic effect ( i.e . tendency increase heart rate ) , two ( phenylephrine vasopressin ) less propensity chronotropy . The potential benefit chronotropic effect patient shock ( increase cardiac output ) offset potential detriment ( predilection tachydysrhythmias myocardial ischemia ) . Recent evidence suggest tachydysrhythmias associate bad outcome ICU patient . One study demonstrate administration beta block agent esmolol improve hemodynamic outcome survival patient septic shock . It clear vasoactive drug regimen utilizes phenylephrine vasopressin associate low heart rate compare regimen utilizes norepinephrine epinephrine . The investigator hypothesis ICU patient shock , use vasoactive drug phenylephrine vasopressin reduce tachydysrhythmias compare norepinephrine epinephrine . To investigate hypothesis , conduct randomize double blind control trial compare phenylephrine vasopressin vs. norepinephrine epinephrine ICU patient shock responsive IV fluid . All patient admit adult intensive care unit University Chicago screen eligibility . Patients randomize receive either phenylephrine ( 0.3-3.0 mcg/kg/minute ) , addition vasopressin ( 0.1-0.6 milliunits/kg/minute ) second vasopressor require , norepinephrine ( 0.03 0.3 mcg/kg/minute ) , addition epinephrine ( 0.03 0.3 mcg/kg/minute ) second vasopressor require . These drug mix blind research pharmacy . Only research pharmacist know identity particular vasoactive drug . As per current standard practice , medical team charge patient determine target blood pressure . In either group , two vasoactive drug adequate raise blood pressure target level , open-label norepinephrine add . If three vasoactive drug inadequate raise blood pressure target level , open-label epinephrine add . There twelve-hour period initiation standard , non-study vasoactive support patient consent enrolled . This allow research team contact patient and/or family order obtain informed consent . Once randomize , patient initiate study drug vasoactive support 50 percent maximal infusion rate . The study drug titrate maintain blood pressure initial non-study drug titrate . The primary team direct aspects patient care . We plan examine follow pre-specified sub-groups : 1 . Patients receive corticosteroid ICU stay vs. patient receive corticosteroid ICU stay 2 . Patients depressed leave ventricular ejection fraction ( &lt; 40 % ) vs. patient normal leave ventricular ejection fraction 3 . Patients coronary artery disease vs. patient without know coronary artery disease 4 . Patients different etiology shock ( i.e . septic , cardiogenic , hypovolemic )</detailed_description>
	<mesh_term>Shock</mesh_term>
	<mesh_term>Phenylephrine</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Oxymetazoline</mesh_term>
	<mesh_term>Norepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<mesh_term>Vasopressins</mesh_term>
	<mesh_term>Arginine Vasopressin</mesh_term>
	<mesh_term>Vasoconstrictor Agents</mesh_term>
	<criteria>1 . Age great equal 18 year old 2 . Requirement vasoactive drug via central venous catheter treatment shock . Shock define mean arterial pressure le 70 mmHg systolic blood pressure le 100 mmHg despite administration least 1000 mL crystalloid 500 mL colloid , unless elevation central venous pressure &gt; 12 mmHg pulmonary artery occlusion pressure &gt; 14 mmHg couple sign tissue hypoperfusion ( e.g . alter mental state , mottle skin , urine output &lt; 0.5 mL/kg body weight one hour , serum lactate level &gt; 2 mmol per liter ) . 1 . Cardiopulmonary arrest 2 . Pregnancy 3 . Severe right heart failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Shock</keyword>
	<keyword>Vasopressor agent</keyword>
	<keyword>Norepinephrine</keyword>
	<keyword>Epinephrine</keyword>
	<keyword>Phenylephrine</keyword>
	<keyword>Vasopressin</keyword>
	<keyword>Atrial fibrillation</keyword>
	<keyword>Tachyarrhythmia</keyword>
</DOC>